China Pharma Holdings (CPHI) EPS (Basic) Growth (3y) (2014 - 2026)
China Pharma Holdings (CPHI) EPS (Basic) Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | 77.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.25% |
| Dec 31, 2025 | 71.28% |
| Sep 30, 2025 | 72.29% |
| Jun 30, 2025 | 73.95% |
| Mar 31, 2025 | 71.91% |
| Dec 31, 2024 | 59.60% |
| Sep 30, 2024 | 58.42% |
| Jun 30, 2024 | 53.80% |
| Mar 31, 2024 | 55.78% |
| Dec 31, 2023 | 35.95% |
| Sep 30, 2023 | 36.68% |
| Jun 30, 2023 | -180.06% |
| Mar 31, 2023 | 27.03% |
| Dec 31, 2022 | 61.76% |
| Sep 30, 2022 | 0.57% |
| Jun 30, 2022 | 1.60% |
| Mar 31, 2022 | -31.37% |
| Dec 31, 2021 | 50.40% |
| Sep 30, 2021 | 25.00% |
| Jun 30, 2021 | 7.86% |